Zoetis Inc. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Zoetis Inc. stock issued during period, shares, new issues for the quarter ending 2014-09-28 was 14.07K shares.
- Zoetis Inc. stock issued during period, shares, new issues for the quarter ending 2014-06-29 was -618.67K shares.
- Zoetis Inc. stock issued during period, shares, new issues for the quarter ending 2014-03-30 was 704.67K shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2014-09-28 | 14.07K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | |
| 2014-06-29 | -618.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | |
| 2014-03-30 | 704.67K shares 10-Q · filed 2014-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |